AU2022300611A1 - Method for producing benzoxazole derivative having bicyclic piperazine ring or salt thereof, and method for producing material thereof - Google Patents

Method for producing benzoxazole derivative having bicyclic piperazine ring or salt thereof, and method for producing material thereof Download PDF

Info

Publication number
AU2022300611A1
AU2022300611A1 AU2022300611A AU2022300611A AU2022300611A1 AU 2022300611 A1 AU2022300611 A1 AU 2022300611A1 AU 2022300611 A AU2022300611 A AU 2022300611A AU 2022300611 A AU2022300611 A AU 2022300611A AU 2022300611 A1 AU2022300611 A1 AU 2022300611A1
Authority
AU
Australia
Prior art keywords
formula
group
compound
compound represented
tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022300611A
Other languages
English (en)
Inventor
Kenichi Fushihara
Satoshi ISSHIKI
Shinsuke Mouri
Masayuki Okue
Toshiro Sasaki
Takeshi Tsumura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Pharma Co Ltd
Original Assignee
Meiji Seika Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Pharma Co Ltd filed Critical Meiji Seika Pharma Co Ltd
Publication of AU2022300611A1 publication Critical patent/AU2022300611A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995Pyrazines or piperazines forming part of bridged ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Health & Medical Sciences (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
AU2022300611A 2021-06-30 2022-06-30 Method for producing benzoxazole derivative having bicyclic piperazine ring or salt thereof, and method for producing material thereof Pending AU2022300611A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021-108230 2021-06-30
JP2021108230 2021-06-30
PCT/JP2022/026168 WO2023277120A1 (ja) 2021-06-30 2022-06-30 二環性ピペラジン環を有するベンゾオキサゾール誘導体又はその塩の製造方法、並びに、その原料の製造方法

Publications (1)

Publication Number Publication Date
AU2022300611A1 true AU2022300611A1 (en) 2024-01-25

Family

ID=84691891

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022300611A Pending AU2022300611A1 (en) 2021-06-30 2022-06-30 Method for producing benzoxazole derivative having bicyclic piperazine ring or salt thereof, and method for producing material thereof

Country Status (12)

Country Link
US (1) US20240309010A1 (https=)
EP (1) EP4365174A4 (https=)
JP (2) JP7476431B2 (https=)
KR (1) KR20240027603A (https=)
CN (2) CN121873082A (https=)
AR (1) AR126290A1 (https=)
AU (1) AU2022300611A1 (https=)
BR (1) BR112023025934A2 (https=)
CA (1) CA3223354A1 (https=)
IL (1) IL309736A (https=)
MX (1) MX2023014123A (https=)
WO (1) WO2023277120A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9890142B2 (en) * 2013-07-10 2018-02-13 Meiji Seika Pharma Co., Ltd. PDE4 inhibitor
MX389276B (es) * 2016-12-26 2025-03-20 Meiji Seika Pharma Co Ltd Compuesto novedoso y sal de este aceptable desde el punto de vista farmacologico.
KR102931303B1 (ko) * 2018-06-27 2026-02-25 메이지 세이카 파루마 가부시키가이샤 염증성 질환, 자가면역 질환, 섬유화 질환 및 암 질환의 치료제
JP2021155336A (ja) * 2018-06-27 2021-10-07 Meiji Seikaファルマ株式会社 新規pde4阻害剤

Also Published As

Publication number Publication date
JP7839217B2 (ja) 2026-04-01
CN117295744A (zh) 2023-12-26
EP4365174A4 (en) 2025-07-02
US20240309010A1 (en) 2024-09-19
KR20240027603A (ko) 2024-03-04
MX2023014123A (es) 2023-12-12
BR112023025934A2 (pt) 2024-02-27
JP7476431B2 (ja) 2024-04-30
EP4365174A1 (en) 2024-05-08
WO2023277120A1 (ja) 2023-01-05
CN121873082A (zh) 2026-04-17
AR126290A1 (es) 2023-10-04
TW202311242A (zh) 2023-03-16
JP2024096941A (ja) 2024-07-17
JPWO2023277120A1 (https=) 2023-01-05
IL309736A (en) 2024-02-01
CA3223354A1 (en) 2023-01-05

Similar Documents

Publication Publication Date Title
AU2022202535B2 (en) Methods and intermediates for preparing a therapeutic compound useful in the treatment of retroviridae viral infection
AU2022202936A1 (en) Improved process for preparing aminopyrimidine derivatives
US20090005597A1 (en) Process for Preparing Substituted Biphenyls
KR20190034231A (ko) 신규 화합물 및 이의 제조방법
IL271974B (en) Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same
US8455689B2 (en) Process for preparing substituted biphenylanilides
CN103224436A (zh) 一种邻氨基二芳基甲酮化合物的制备方法
WO2013080215A1 (en) An improved process for the preparation of flupirtine and pharmaceutically acceptable salts thereof
WO2012040845A1 (en) Process for the preparation of tetracyclic derivatives and intermediate products used in the process
AU2022300611A1 (en) Method for producing benzoxazole derivative having bicyclic piperazine ring or salt thereof, and method for producing material thereof
RU2858377C2 (ru) Способ получения производного бензоксазола, содержащего бициклическое пиперазиновое кольцо, или его соли и способ получения исходного вещества для него
CN111333561B (zh) 一种拉洛替尼中间体(2r)-2-(2,5-二氟苯基)吡咯烷的合成方法
HU195780B (en) Process for production of derivatives of substituated dihydroquinolone carbonic acid
AU2008290000B2 (en) Method for producing quinazoline derivative
TWI915570B (zh) 具有二環性哌嗪環之苯并噁唑衍生物或其鹽之製造方法以及其原料之製造方法
US9969735B2 (en) Process for making tricyclic lactam compounds
CN104592222A (zh) 抗血小板药物azd6482的制备方法
US6774231B2 (en) Method for the preparation of oxazolidinones
CA1051887A (en) Triazolo (4,3-d) (1,4) benzodiazepine-3,6-diones
AU2002255804A1 (en) A method for the preparation of oxazolidinones